• 1
    Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997;159:383848.
  • 2
    Gramaglia I, Cooper D, Miner KT, Kwon BS, Croft M. Co-stimulation of antigen-specific CD4 T cells by 4–1BB ligand. Eur J Immunol 2000;30:392402.DOI: 10.1002/(sici)1521-4141(200002)30:02<392::aid-immu392>;2-4
  • 3
    Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767811.
  • 4
    Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998;10:15938.DOI: 10.1093/intimm/10.11.1593
  • 5
    De-Saint VB, Fugier VI, Massacrier C et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998;160:166676.
  • 6
    Zhou LJ & Tedder TF. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 1995;86:3295301.
  • 7
    Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997;158:422936.
  • 8
    Lindhout E, Figdor CG, Adema GJ. Dendritic cells: migratory cells that are attractive. Cell Adhes Commun 1998;6:11723.
  • 9
    Lanzavecchia A. Immunology. Licence to kill [news; comment]. Nature 1998;393:4134.DOI: 10.1038/30845
  • 10
    Ridge JPRF & Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell [see comments]. Nature 1998;393:4748.DOI: 10.1038/30989
  • 11
    Caux C, Massacrier C, Vanbervliet B, Van Dubois BKC, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:126372.
  • 12
    Zhou LJ & Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996;93:258892.
  • 13
    Caux C, Dezutter DC, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:25861.
  • 14
    Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 1997;90:36406.
  • 15
    Buelens C, De Verhasselt VGD, Thielemans K, Goldman M, Willems F. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol 1997;27:184852.
  • 16
    Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998;161:30429.
  • 17
    Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999;96:930510.
  • 18
    Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999;189: 8219.
  • 19
    Terheyden P, Straten P, Brocker EB, Kampgen E, Becker JC. CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes. J Immunol 2000;164:66339.
  • 20
    Kuniyoshi JS, Kuniyoshi CJ, Lim AM et al. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell Immunol 1999;193:4858.DOI: 10.1006/cimm.1999.1469
  • 21
    Chakraborty A, Li L, Chakraborty NG, Mukherji B. Stimulatory and inhibitory differentiation of human myeloid dendritic cells. Clin Immunol 2000;94:8898.DOI: 10.1006/clim.1999.4826
  • 22
    Kalinski P, Schuitemaker JH, Hilkens CM, Kapsenberg ML. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol 1998;161:28049.
  • 23
    Yang S, Darrow TL, Vervaert CE, Seigler HF. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell Immunol 1997;179:8495.DOI: 10.1006/cimm.1997.1151
  • 24
    Labeur MS, Roters B, Pers B et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999;162:16875.
  • 25
    Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells [see comments]. Nat Med 1998;4:32832.
  • 26
    Brossart P, Wirths S, Stuhler G, Reichardt VL, Kanz L, Brugger W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 2000;96: 3102811–1.
  • 27
    Shimizu Y, Guidotti LG, Fowler P, Chisari FV. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998;161:45209.
  • 28
    Diehl LBA, Schoenberger SP, Van-der VE et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med 1999;5:7749.DOI: 10.1038/10495
  • 29
    Wurtzen P, Wissenbach M, Ipsen H, Bufe A, Van Arnved J, NR. Highly heterogeneous Phl, p 5-specific T cells from patients with allergic rhinitis differentially recognize recombinant Phl, p 5 isoallergens. J Allergy Clin Immunol 1999;104:11522.
  • 30
    Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:8393.
  • 31
    Bakker AB, De Marland GBA, Huijbens RJ, Danen EH, Adema GJ, Figdor CG. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 1995;55:53304.
  • 32
    O'Doherty U, Steinman RM, Peng M et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 1993;178:106776.
  • 33
    Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi CP. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998;188:217580.
  • 34
    Gieseler R, Heise D, Soruri A, Schwartz P, Peters JH. In vitro differentiation of mature dendritic cells from human blood monocytes. Dev Immunol 1998;6:2539.
  • 35
    Schoenberger SP, Toes RE, Van-der VE, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions [see comments]. Nature 1998;393:4803.DOI: 10.1038/31002
  • 36
    Caux C, Massacrier C, Vanbervliet B, Van Dubois BKC, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:126372.
  • 37
    Pietschmann P, Stockl J, Draxler S, Majdic O, Knapp W. Functional and phenotypic characteristics of dendritic cells generated in human plasma supplemented medium. Scand J Immunol 2000;51:377–83Jul.
  • 38
    Larsson M, Messmer D, Somersan S et al. Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. J Immunol 2000; 165:118290.
  • 39
    Zarling AL, Johnson JG, Hoffman RW, Lee DR. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells. J Immunol 1999;162:5197204.
  • 40
    Mosca PJ, Hobeika AC, Clay TM et al. A subset of human monocyte–derived dendritic cells expresses high levels of interleukin−12 in response to combined CD40 ligand and interferon–gamma treatment. Blood 2000;96:34993504.